Dana Murray

990 citations
17 papers · 769 indexed · h-index 12
Topics
MicroRNA in disease regulation (4 papers)Adipokines, Inflammation, and Metabolic Diseases (4 papers)Adipose Tissue and Metabolism (3 papers)

In The Last Decade

Dana Murray

17 papers receiving 757 citations

Peers

Dana Murray
Comparison fields: 5 of 86
  • Molecular Biology 388
  • Physiology 193
  • Cancer Research 128
  • Epidemiology 123
  • General Health Professions 88
Replace Peter Oelzner with:
Peter Oelzner Germany
Bo Young Yoon South Korea
Chen Dong China
Takashi Iwata Japan
Chiara Giannitti Italy
Christian Schulz Germany
Liu P China
Fiona E. Watt United Kingdom
F. P. Cantatore Italy
Dana Murray relative to Peter Oelzner Germany Peter Oelzner's profile →
Citations per field
00.5×7.3×
Peter Oelzner · 1×
Citations per year

Countries citing papers authored by Dana Murray

Since Specialization
Citations

This map shows the geographic impact of Dana Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Murray more than expected).

Fields of papers citing papers by Dana Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Murray. The network helps show where Dana Murray may publish in the future.

Co-authorship network of co-authors of Dana Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Murray. A scholar is included among the top collaborators of Dana Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Murray. Dana Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 5
2 14
3 28
4 4
5
Effect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests
3
6 144
7 96
8 56
9 41
10 64
11 112
12 2
13 53
14 71
15 5
16 27
17 44

About Dana Murray

Dana Murray is a scholar working on Family Practice, Cancer Research and Health Information Management, having authored 17 papers that have together received 769 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Adipokines, Inflammation, and Metabolic Diseases (4 papers) and Adipose Tissue and Metabolism (3 papers). The work is most often cited by research in Family Practice (26 citations), Cancer Research (128 citations) and Orthopedics and Sports Medicine (65 citations). Dana Murray has collaborated with scholars based in United States, China and South Korea. Frequent co-authors include Qisheng Tu, Jake Y. Chen, Liming Yu, Lan Zhang, Paloma Valverde, Shu Meng, Michel Dard, Xiaofang Zhu, Yuwei Wu and Yin Tang. Their work appears in journals such as Biomaterials, Journal of Bone and Mineral Research and Acta Biomaterialia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026